| Cytoplasmic steps of peptidoglycan biosynthesis H Barreteau, A Kovač, A Boniface, M Sova, S Gobec, D Blanot FEMS microbiology reviews 32 (2), 168-207, 2008 | 889 | 2008 |
| Antioxidant and antimicrobial activities of cinnamic acid derivatives M Sova Mini reviews in medicinal chemistry 12 (8), 749-767, 2012 | 568 | 2012 |
| Natural sources, pharmacokinetics, biological activities and health benefits of hydroxycinnamic acids and their metabolites M Sova, L Saso Nutrients 12 (8), 2190, 2020 | 124 | 2020 |
| Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53) B Korošec, M Sova, S Turk, N Kraševec, M Novak, L Lah, J Stojan, ... Journal of applied microbiology 116 (4), 955-966, 2014 | 94 | 2014 |
| Design and development of Nrf2 modulators for cancer chemoprevention and therapy: A review M Sova, L Saso Drug design, development and therapy, 3181-3197, 2018 | 83 | 2018 |
| Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities D Knez, N Coquelle, A Pišlar, S Žakelj, M Jukič, M Sova, J Mravljak, ... European journal of medicinal chemistry 156, 598-617, 2018 | 83 | 2018 |
| Antimicrobial activity of trans‐cinnamic acid and commonly used antibiotics against important fish pathogens and nonpathogenic isolates S Yilmaz, M Sova, S Ergün Journal of Applied Microbiology 125 (6), 1714-1727, 2018 | 73 | 2018 |
| Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 P Brožič, P Kocbek, M Sova, J Kristl, S Martens, J Adamski, S Gobec, ... Molecular and cellular endocrinology 301 (1-2), 229-234, 2009 | 68 | 2009 |
| Synthesis and structure–activity relationship study of novel quinazolinone-based inhibitors of MurA M Hrast, K Rožman, M Jukič, D Patin, S Gobec, M Sova Bioorganic & Medicinal Chemistry Letters 27 (15), 3529-3533, 2017 | 64 | 2017 |
| Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF M Sova, A Kovač, S Turk, M Hrast, D Blanot, S Gobec Bioorganic chemistry 37 (6), 217-222, 2009 | 56 | 2009 |
| Flavonoids and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: A synthesis, QSAR and modelling study M Sova, A Perdih, M Kotnik, K Kristan, TL Rižner, T Solmajer, S Gobec Bioorganic & medicinal chemistry 14 (22), 7404-7418, 2006 | 52 | 2006 |
| Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease D Knez, M Sova, U Košak, S Gobec Future medicinal chemistry 9 (8), 811-832, 2017 | 48 | 2017 |
| Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB) M Sova, G Čadež, S Turk, V Majce, S Polanc, S Batson, AJ Lloyd, ... Bioorganic & Medicinal Chemistry Letters 19 (5), 1376-1379, 2009 | 46 | 2009 |
| Novel toll-like receptor 4 (TLR4) antagonists identified by structure-and ligand-based virtual screening U Švajger, B Brus, S Turk, M Sova, V Hodnik, G Anderluh, S Gobec European journal of medicinal chemistry 70, 393-399, 2013 | 44 | 2013 |
| Indoleamine and tryptophan 2, 3-dioxygenases as important future therapeutic targets A Dolšak, S Gobec, M Sova Pharmacology & Therapeutics 221, 107746, 2021 | 42 | 2021 |
| Stereoselective activity of 1-propargyl-4-styrylpiperidine-like analogues that can discriminate between monoamine oxidase isoforms A and B D Knez, N Colettis, LG Iacovino, M Sova, A Pišlar, J Konc, S Lešnik, ... Journal of medicinal chemistry 63 (3), 1361-1387, 2020 | 40 | 2020 |
| Reaching toward underexplored targets in antibacterial drug design M Jukič, S Gobec, M Sova Drug development research 80 (1), 6-10, 2019 | 40 | 2019 |
| Cinnamic acid esters as potent inhibitors of fungal 17β-hydroxysteroid dehydrogenase––a model enzyme of the short-chain dehydrogenase/reductase superfamily S Gobec, M Sova, K Kristan, TL Rižner Bioorganic & medicinal chemistry letters 14 (15), 3933-3936, 2004 | 40 | 2004 |
| Cobalt-catalyzed cross-coupling of Grignards with allylic and vinylic bromides: use of sarcosine as a natural ligand R Frlan, M Sova, S Gobec, G Stavber, Z Casar The Journal of Organic Chemistry 80 (15), 7803-7809, 2015 | 37 | 2015 |
| Farmacevtska kemija III: Vaje in seminarji M Anderluh, J Mravljak, A Perdih, M Sova, S Pečar Fakulteta za farmacijo, 2010 | 37 | 2010 |
